Overview

Bioequivalence Study of Empagliflozin 25 mg Film-coated Tablets in Healthy Thai Volunteers

Status:
NOT_YET_RECRUITING
Trial end date:
2024-07-13
Target enrollment:
Participant gender:
Summary
To determine and compare the rate and extent of absorption of a test formulation with that of a reference innovator formulation when given as equal labeled dose in healthy subjects under fasting conditions
Phase:
PHASE1
Details
Lead Sponsor:
International Bio service
Treatments:
empagliflozin